XWXuefeng Wang

Xuefeng Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xuefeng Wang has a total of 88 co-authors. Here are the top co-authors by number of shared publications:

  • Hua Xu

    Department of Pediatric, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

    2 shared publications
  • Shiyao Zhang

    First Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, People’s Republic of China

    2 shared publications
  • Xiuying Zhang

    The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, 110032, China

    2 shared publications
  • Xiuying Zhang

    Department of Pediatrics, The First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, People’s Republic of China

    2 shared publications
  • Yan Huang

    2 shared publications
  • Bao-Qing Zhang

    Department of Pediatric, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China

    1 shared publication

Latest Publications

  • Open Access

    Etiology and Epidemiology of Acute Lower Respiratory Infections Among Hospitalized Pediatric Patients in Northeastern China: A Retrospective Study from 2023 to 2025

    by Hang-Yu Zhao, Shi-Yao Zhang, Rui Wang, Xiu-Ying Zhang, Xue-Feng Wang

    Purpose: To analyze the etiological and epidemiological characteristics of acute lower respiratory infection (ALRI) in hospitalized children in Northeast China (Shenyang, Liaoning Province) following the lifting of non-pharmaceutical interventions (NPIs). Patients and Methods: Clinical data and test results for 12 respiratory pathogens from 26,721 hospitalized children with ALRI admitted to two hospitals in Shenyang between January 2023 and December 2025 were retrospectively analyzed. Pathogen detection was performed using polymerase chain reaction (PCR) or serological methods. To control for diagnostic heterogeneity, analyses were stratified by PCR and serology as follows: chi-square test for age, gender, and seasonal distributions; multivariate logistic regression for independent factors associated with pathogen positivity; and Spearman’s rank correlation test for associations between meteorological factors and monthly positivity rates. Results: PCR testing showed that rhinovirus (RV) had the highest positivity rate (13.80%), followed by influenza A virus (IAV) and respiratory syncytial virus (RSV). RSV was most common in infants aged < 1 year, while RV and IAV were more common in children aged 3-< 6 years. The positivity rate of RV was higher in males than in females (P < 0.001). IAV and RSV peaked in winter and spring, whereas RV peaked in summer. Serological testing showed that Mycoplasma pneumoniae (MP) had the highest positivity rate (37.64%), followed by RSV and adenovirus (ADV). The detection peaks of MP and ADV were concentrated in children aged 6– 14 years. The positivity rates of Epstein-Barr virus (EBV), MP, and Chlamydia pneumoniae (Cpn) were lower in males than in females (all P < 0.05). MP peaked in autumn and winter, while IAV peaked in winter. The age and seasonal distribution patterns of RSV were consistent with those from PCR testing. Age, season, and gender were independent influencing factors for pathogen infection. Meteorological factors were significantly correlated with monthly positivity rates of specific pathogens (P < 0.05). Conclusion: Following the lifting of NPIs, the pathogen spectrum of childhood ALRI in Shenyang presented distinct seasonal, age, and gender differences. Age, season, and gender were independent influencing factors for pathogen infection. Although methodological differences exist between PCR and serological testing, comparisons within the same detection method are generally reliable.

  • Influence and lagged effects of weather and air pollution on pediatric RSV-ALRI in Shenyang, NE China

    by Shiyao Zhang, Ci Chen, Rui Wang, LuanXiong Liu, Xuefeng Wang, Xiuying Zhang

  • Open Access

    [Patterns and mechanisms of the "treating skin with skin" therapy under traditional Chinese medicine analogical thinking based on data mining and network pharmacology].

    by Xiaoli Hu, Hui Guo, Guoyan Sun, Xuefeng Wang

    Under the guidance of analogical thinking in traditional Chinese medicine (TCM), the "treating of skin with skin" therapy, using processed animal and plant skin-derived medicinal materials to treat skin diseases, has a long history but lacks scientific evidence-based support. This study aims to apply data mining and network pharmacology techniques to explore the prescription patterns and mechanisms of action of the "treating skin with skin" therapy, and to interpret its rationality, effectiveness, and scientific basis using modern scientific methods. Relevant literature from Chinese and English databases over the past 20 years was retrieved and integrated according to inclusion and exclusion criteria. Data were integrated and mined using software such as Excel, OriginPro 2021, and SPSS Modeler 18.0. Frequency analysis, cluster analysis, and association rule analysis were performed sequentially to summarize high-frequency plant skin-derived Chinese medicinal materials and extract the core prescription. Core prescription drugs and skin disease-related gene targets were obtained from drug and disease target databases, including the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform and GeneCards. Intersection targets were identified using Venny 2.1.0, and core targets were further extracted. Protein-protein interaction (PPI) network analysis, Gene Ontology (GO) functional enrichment analysis, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were conducted for the intersection targets, and finally a "core drug-component-target-pathway" network was constructed and visualized. Based on the inclusion and exclusion criteria, 563 eligible articles were ultimately included, from which 32 prescriptions were extracted, involving 21 plant skin-derived Chinese medicinal materials. Among them, 15 medicinal materials had a usage frequency exceeding 50%, with bitter, sweet, and cold properties predominating. Cluster analysis yielded 4 effective clusters. Cluster 1: Phellodendron cortex-Dictamni cortex; Cluster 2: Eucommia cortex-Mori cortex-Meliae cortex-Pseudolaricis cortex; Cluster 3: Moutan cortex-Poriae Cutis-Lycii cortex-Fraxini cortex-Acanthopanacis cortex-Benincasae Pericarpium; Cluster 4: Ailanthi cortex-Periplocae cortex-Erycibes cortex. Association rule analysis generated 92 association rules, with 4 strong links, 90 moderate links, and 10 weak links between herb pairs. Based on the association rules and linkage strength, the core prescription of the "treating skin with skin" therapy was summarized as "Phellodendri Cortex-Moutan Cortex-Dictamni Cortex-Benincasae Pericarpium-Poriae Cutis-Lycii Cortex." A total of 46 active ingredients were screened from this core prescription, involving 781 gene targets. A total of 2 537 skin disease-related gene targets were retrieved, yielding 212 intersection targets between the core prescription and the disease. PPI network analysis of the intersection targets showed 2 723 edges among 212 nodes, with an average node degree of 25.9 and an average local clustering coefficient of 0.554. The PPI network of core targets contained 50 nodes and 784 edges; the top three core nodes by degrees were interleukin-6 (IL-6; 116), tumor necrosis factor (TNF; 115), and interleukin-1 beta (IL-1β; 110). GO analysis yielded 732 biological process terms, with the top 3 being response to lipopolysaccharide, positive regulation of DNA-templated transcription, and positive regulation of microRNA (miRNA) transcription; 90 cellular component terms, with the top 3 being extracellular space, extracellular region, and chromatin; and 153 molecular function terms, with the top 3 being enzyme binding, nuclear receptor activity, and identical protein binding. KEGG analysis identified 166 enriched signaling pathways, with the top 3 being pathways in cancer, lipid and atherosclerosis, and the advanced glycation end products-receptor for advanced glycation end products pathway in diabetic complications. The visualized "core drug-component-target-pathway" network comprised 854 nodes and 1 911 edges, with a network centralization coefficient of 0.182 and a characteristic path length of 3.985; the top 3 nodes by degree were all drug components, namely vitamin E, vitamin B, and trigonelline. Guided by TCM analogical thinking, the core prescription of the "treating skin with skin" therapy exerts therapeutic effects on skin diseases through synergistic actions involving multiple components, multiple targets, and multiple pathways. Its effect is significant, the rationale is well founded, and its origins are well established.

  • Open Access

    Study Protocol: A Randomized Multicenter Study on Clinical-efficacy Evaluation of Xiaoer Dingchuan Granule in Children with Respiratory Syncytial-virus Pneumonia

    by Ruixue Li, Xuefeng Wang, Xiuying Zhang, Hui Wang, Jiayuan Liu

    Background Respiratory syncytial virus (RSV) pneumonia is a major cause of hospitalization in children worldwide, seriously endangering child health. In recent years, many clinical studies have shown that traditional Chinese medicine (TCM) has unique advantages in the treatment of pediatric viral pneumonia. Therefore, it is particularly important to strengthen exploration of and research into the use of TCM to treat RSV pneumonia in children. The aims of this study will be to evaluate the clinical effect of Xiaoer Dingchuan Granule (XDG) on RSV pneumonia and to provide a scientific basis for clinical diagnosis and treatment. Methods and Design: This study will be a single-blinded, parallel-controlled, multicenter randomized clinical trial (RCT) conducted in 10 Class III Grade A hospitals nationwide. We will recruit the study population from children aged 1–5 years who have been diagnosed with RSV pneumonia by Western medicine and with pneumonia and cough by TCM (phlegm-heat blocking lung syndrome) with a disease course within 48 h. The children’s parents or guardians will sign their informed consent. A total of 240 children will be recruited and divided into an experimental group and a control group. The control group will receive basic treatment, and the experimental group will receive XDG. Children will be treated for 7 days, and changes in their conditions will be evaluated daily and input to the medical-record observation form. We will follow-up on them at 10 and 90 days after discharge to observe their prognosis. After data collection, we will comprehensively evaluate the clinical efficacy of pediatric XDG as intervention into syncytial-virus pneumonia by its total effective rate, the curative-effect time window of pediatric pneumonia, the curative effect of TCM syndrome, changes in individual symptoms, changes in pulmonary signs, and the use of drug combinations. Discussion We speculate that treatment of RSV pneumonia in children with TCM can increase the overall clinical efficiency, alleviate disease severity, shorten hospital stays, reduce pain, and improve the children’s quality of life. Trial Registration: Chinese Clinical Trial Registry No. ChiCTR2200061471

    • 1 January 2019
      • Vol. 21  (1) , 11-17

    全国多地区儿童社区获得性肺炎住院患儿抗菌药物使用情况分析

    by Wei Wei, Xue-Feng Wang, Jian-Ping Liu, Kun-Ling Shen, Rong Ma, Zhen-Ze Cui, Li Deng, Yan-Ning Li, Zhi-Yan Jiang, Hua Xu, et al.

    统计全国多地区儿童社区获得性肺炎(CAP)抗菌药物的使用情况,为进一步加强儿童CAP的规范治疗及抗菌药物合理使用提供参考依据。 统计2014年4月14日至2016年1月1日全国9个城市10家三甲医院儿科住院的1 383例CAP患儿的抗菌药物使用情况,分析华北、东北、华东、华南4个区域住院患儿的抗菌药物使用情况。 CAP患儿抗菌药物总使用率为89.08%,其中华北88.7%,东北95.5%,华东83.3%,华南86.6%。使用种类主要为头孢类、大环内酯类、β内酰胺类抗菌药物的复方制剂、多磷类广谱抗菌药物、其他β内酰胺类抗菌药物。抗菌药物的选用基本合理,但仍存在单纯病毒感染时使用抗菌药物、单纯感染时联用抗菌药物等现象;抗菌药物的不合理应用例数共有131例,不合理使用率为10.63%。 儿童CAP抗菌药物使用率、不合理用药率偏高,应加强对儿童CAP抗菌药物使用的规范化管理。


  • Open Access

    A cross-sectional study of the clinical characteristics of hospitalized children with community-acquired pneumonia in eight eastern cities in China

    by Xue-Feng Wang, Jian-Ping Liu, Kun-Ling Shen, Rong Ma, Zhen-Ze Cui, Li Deng, Yun-Xiao Shang, De-Yu Zhao, Li-Bo Wang, Li-Ya Wan, et al.

    Community-acquired pneumonia in children is common in China. To understand current clinical characteristics and practice, we conducted a cross-sectional study to analyze quality of care on childhood pneumonia in eight eastern cities in China.


  • Open Access

    Evaluation of the Use of Different Solvents to Extract the Four Main Components of Yinqiaosan and Their In Vitro Inhibitory Effects on Influenza‐A Virus

    by Xuefeng Wang, Oumei Hao, Wenli Wang, Xixiang Ying, Huailiang Wang

    High-performance liquid chromatography coupled with an ultraviolet detector was used to quantitatively determine the amount of caffeoylquinic acid, arctium lappa glycoside, aurantiamarin and forsythin present in five solvent extracts (water, 30% ethanol, 50% ethanol, 70% ethanol and 95% ethanol) of Yinqiaosan (YQS). The calibration curves of the four components were linear (r(2) > 0.998) over the concentration range of 0.9-151.5 microg/mL. This method showed good repeatability with relative standard deviations of less than 2.9% and mean recoveries of 91.3-100.5%. We established the relative amounts of each of the four main ingredients in YQS for all five solvent extracts. The direct inhibitory effects of the five YQS extracts on influenza-A virus in vitro and the therapeutic effects on infected embryonated hen eggs were evaluated. YQS extracted in 50% ethanol and used at concentrations of 500 mg/mL and 250 mg/mL exerted the greatest therapeutic effect in infected embryonated hen eggs and was significantly superior to ribavirin (p < 0.05). Therefore, the 50% ethanol extract of YQS seems to be the most effective for the inhibition of influenza-A virus. Based on these results, further studies are warranted to evaluate the use of YQS extracts as a possible therapy for influenza.